Find trials
Search tips

Towards Precise and Rapid Diagnosis of Heparin-Induced Thrombocytopenia: a Prospective, Multicentre Cohort Study (“TORADI-HIT”)

Overview

About this study

The purpose of this study is to develop and validate a clinical prediction rule for the diagnosis of HIT.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Anti-PF4/heparin antibody test requested, or
  • Clinical assessment tool (4Ts score) applied

Exclusion Criteria:

  • Age below 18 years, or
  • General informed consent of the institution not provided, or
  • No residual serum sample available, or
  • No in-house patient

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Prakash Vishnu, M.B.B.S.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20426515

Mayo Clinic Footer